Beauty experts target Ozempic face fears

The article discusses how beauty experts exploit patients' fears of aesthetic changes resulting from weight loss medications associated with the "Ozempic face." The demand for treatments that reduce facial sagging and restore the lost fat volume after rapid weight loss is increasing, especially with the rising sales of obesity drugs—which could reach $150 billion annually by 2030. Companies like Galderma and L'Oréal promote treatments such as collagen injections and fillers to diminish skin changes, although the limited effectiveness of creams falls short of restoring lost volume or correcting deep fat accumulations. In conclusion, beauty specialists continue to develop solutions to address the changes caused by weight loss drugs, recognizing that volume loss is often related to decreased subcutaneous fat, and that topical products have limitations in correcting these alterations.